GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 25 Biotech Companies of 2024 - genengnews.com
Jan 12, 2024 · Just missing the list at number 26 is BioMarin Pharmaceutical, which had a market cap of $17.51 billion on December 8, followed by WuXi Biologics ($15.94 billion), UCB ($15.52 billion), Novozymes ...
Top 10 Biomedical Issues of the Next Decade - genengnews.com
Feb 1, 2020 · Gene therapies are still in use, but genetic medicine and counseling are shifting toward prevention. Some governments are taking an interest in encouraging gene editing to control the high cost of ...
Novartis Automates New Radioligand Therapy Production Plant
Jan 24, 2024 · Automated manufacturing and supply chain management systems will play a key role in running the highly time-sensitive production operations at its new U.S. radioligand therapy facility, says ...
Making History with the 1990 Gene Therapy Trial
Mar 10, 2016 · At the age of four years, DeSilva made history at 12:52 p.m. on September 14, 1990, as the first patient to undergo an approved application of gene therapy. She was part of a trial authorized by ...
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
Feb 1, 2024 · The total value of biotech M&A in 2023 stood at $122.2 billion, up 45% from $84.2 billion a year earlier. The total value of pharma M&A jumped 38% year over year, from $98.5 billion in 2022 to ...
To Reverse Aging’s Clock, Adjust the Cell’s Machinery
October 3, 2024. Morphoceuticals is a biotechnology company that surveys the body’s nonneural bioelectric signaling networks. These networks, which enable disparate cells to serve collective ...
REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to …
Mar 28, 2024 · REGENXBIO and their eye care program partner, AbbVie, have published two-year data from their first-in-human gene therapy study in patients with neovascular age-related macular degeneration (nAMD ...
Top 10 Publicly Owned Gene Editing Therapy Companies
May 31, 2024 · Based in Cambridge, MA, Beam led gene editing companies in 2023 revenue with $377.709 million (it added $7.41 million in Q1) and was second in cash position with $1.19 billion (dipping to $1.095 ...
How CRISPR Is Accelerating Drug Discovery - genengnews.com
Jan 11, 2019 · The drug discovery process begins with preclinical research (steps 1–4). The target of a disease of interest is first identified and validated. A large library of compounds is then screened to ...